SEC Comment Letter 0000000000-23-008873 to OptiNose, Inc. (OPTN) (CIK 0001494650)
OptiNose, Inc. (OPTN) (CIK 0001494650)
Date: Aug. 15, 2023 · CIK: 0001494650 · Accession: 0000000000-23-008873
AI Filing Summary & Sentiment
File numbers found in text: 333-273873
Letter
United States securities and exchange commission logo August 15, 2023 Ramy Mahmoud Chief Executive Officer OptiNose, Inc. 1020 Stony Hill Road, Suite 300 Yardley, PA 19067 Re:OptiNose, Inc. Registration Statement on Form S-3 Filed August 10, 2023 File No. 333-273873 Dear Ramy Mahmoud: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Stephen Nicolai
Show Raw Text
United States securities and exchange commission logo
August 15, 2023
Ramy Mahmoud
Chief Executive Officer
OptiNose, Inc.
1020 Stony Hill Road, Suite 300
Yardley, PA 19067
Re:OptiNose, Inc.
Registration Statement on Form S-3
Filed August 10, 2023
File No. 333-273873
Dear Ramy Mahmoud:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Stephen Nicolai